Objective-Scavenger receptor BI (SR-BI) is a cell surface receptor that promotes the selective uptake of cholesteryl esters from high-density lipoprotein (HDL) by the liver. In mice, SR-BI deficiency results in increased plasma HDL cholesterol levels and enhanced susceptibility to atherosclerosis. The aim of this study was to investigate the role of SR-BI deficiency on platelet function. Methods and Results-SR-BI-deficient mice were thrombocytopenic, and their platelets were abnormally large, probably because of an increased cholesterol content. The FeCl 3 acute injury model to study arterial thrombosis susceptibility showed that SR-BI wild-type mice developed total arterial occlusion after 24Ϯ2 minutes. In SR-BI-deficient mice, however, the time to occlusion was reduced to 13Ϯ1 minutes (Pϭ0.02). Correspondingly, in SR-BI-deficient mice, platelets circulated in an activated state and showed increased adherence to immobilized fibrinogen. In contrast, platelet-specific disruption of SR-BI by bone marrow transplantation in wild-type mice did not alter plasma cholesterol levels or affect platelet count, size, cholesterol content, or reactivity, suggesting that changes in plasma cholesterol levels were responsible for the altered responsiveness of platelets in SR-BI-deficient mice.
Disruption of SR-BI in mice results in a 3.2-fold increase in free cholesterol levels in the circulation, resulting in an unusually high plasma unesterified-to-total cholesterol ratio (UC:TC). 15, 20, 21 Much of this excess cholesterol is carried by HDL particles, reflecting impaired delivery to the liver. This is accompanied by a tendency toward slightly increased levels of very low density lipoprotein-cholesterol levels, whereas low-density lipoprotein-cholesterol levels are not changed. 21 In addition, SR-BI deficiency leads to female infertility, 22, 23 multiple red blood cell defects, 24, 25 and an increased susceptibility to diet-induced atherosclerosis. 21, 22 Disruption of SR-BI in apolipoprotein E-deficient mice results in the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, and premature death. 26 Coronary arterial lesions in these SR-BIϫ apolipoprotein E double knockout mice exhibit extensive fibrin deposition, indicating that SR-BI disruption induces hemorrhage and thrombosis. 22, 26 Interestingly, SR-BI is also expressed in megakaryocytes and platelets. 27 In patients with atherosclerosis, a strong inverse correlation exists between the expression of SR-BI, the ability to aggregate and the cholesterol content of the platelets. 27 Correspondingly, Dole et al described that the high UC:TC ratio observed in SR-BI-deficient mice is associated with (1) thrombocytopenia due to high platelet clearance rates, (2) an increased intracellular cholesterol content, and (3) abnormal platelet morphologies, including an increase in size, due to high intracellular cholesterol content and the young age of the platelets, and the presence of multilamellar structures, probably for accommodation of excess unesterified cholesterol. 28 In the current study, we studied the effects of increased plasma HDL cholesterol levels in SR-BI-deficient mice on platelet physiology. Disruption of SR-BI in mice results in active circulating platelets, increased adherence to immobilized fibrinogen, and increased susceptibility to arterial thrombosis in vivo. Hence, SR-BI is essential not only for HDL cholesterol homeostasis and atherosclerosis susceptibility but also for maintaining normal platelet function and prevention of thrombosis.
Methods
To elucidate the role of SR-BI in platelet function, the susceptibility to in vivo arterial thrombosis of wild-type (SR-BIϩ/ϩ), heterozygous (SR-BIϩ/Ϫ), and homozygous (SR-BIϪ/Ϫ) SR-BI-deficient mice was determined by the FeCl 3 acute injury model. Furthermore, the state of activation of circulating platelets was inferred from the level of surface-expressed P-selectin and the conformational state of integrin ␣ IIb ␤ 3 by flow cytometry, as well as from the level of urinary 2,3-dinor thromboxane B 2 (TxB 2 ) and 2,3-dinor 6-keto prostaglandin F 1␣ by stable dilution isotope gas chromatography/ mass spectrometry assays. Functional consequences of the activation state of the circulating platelets were determined by static adhesion experiments to immobilized fibrinogen, as well as aggregation experiments. Cholesterol content of the murine platelets was studied by Filipin III staining of the platelets adhered to fibrinogen. To assess the influence of the plasma UC:TC ratio on platelet function, bone marrow from either SR-BIϩ/ϩ or SR-BIϪ/Ϫ mice was transplanted into SR-BIϩ/ϩ mice, and platelet function was studied. For a full description of these methods, see the supplemental materials, available online at http://atvb.ahajournals.org.
Results

Thrombocytopenia and the Presence of Large Platelets in SR-BI Deficiency
Hematologic analysis of SR-BIϪ/Ϫ mice on a regular chow diet (5.7% [w/w] fat and no added cholesterol) showed that SR-BI deficiency caused thrombocytopenia: the platelet number in SR-BIϪ/Ϫ mice (415Ϯ97ϫ10 9 platelets/L) was reduced by 55% compared with the number of platelets in SR-BIϩ/ϩ mice (921Ϯ147ϫ10 9 platelets/L; PϽ0.001). No statistically significant difference was observed in the platelet count between SR-BIϩ/ϩ and SR-BIϩ/Ϫ mice (874Ϯ208ϫ10 9 platelets/L; Pϭ0.43) ( Figure 1A ). In addition, platelets from SR-BIϪ/Ϫ mice were abnormally large. Their size (7.3Ϯ0.4 fL) increased 1.2-fold compared with platelets from SR-BIϩ/ϩ or SR-BIϩ/Ϫ mice (both 6.0Ϯ0.2 fL; PϽ0.001, Figure 1B ). Hematology Analyzer (Sysmex Europe GMBH, Norderstedt, Germany). The platelet count was corrected for the addition of anticoagulant. Shown are meansϮSD, nϭ13 to 26, ***PϽ0.001. C, Washed SR-BIϩ/ϩ or SR-BIϪ/Ϫ platelet suspensions (0.5ϫ10 11 platelets/L) were seeded on fibrinogen-coated coverslips and allowed to spread for 60 minutes. After spreading, platelets were fixed, and unesterified cholesterol in the platelets was stained with Filipin III. SR-BI disruption in mice caused a 2.7-fold increase in unesterified cholesterol levels and a 1.7-fold increase in total cholesterol levels in the circulation (supplemental Table I) , mainly because of a rise in HDL-cholesterol. 21 This led to a 1.6-fold increase of the UC:TC ratio in SR-BIϪ/Ϫ mice compared with SR-BIϩ/ϩ mice (PϽ0.001).
Because lipid exchange between plasma lipoproteins and platelets is a predominantly nonspecific process that occurs continuously, we determined the level of unesterified cholesterol in platelets. Adhered platelets were stained with Filipin III, a fluorescent cholesterol binding dye, 29 and visualized microscopically. Figure 1C clearly illustrates that platelets from SR-BIϪ/Ϫ mice contained a higher level of unesterified cholesterol compared with SR-BIϩ/ϩ platelets.
Impaired Platelet Aggregation by SR-BI-Deficient Platelets
Dole et al 28 showed that aggregation of platelet-rich plasma (PRP) from SR-BIϪ/Ϫ mice was impaired after stimulation by ADP. Similarly, we observed that SR-BIϪ/Ϫ platelet responsiveness in PRP was inhibited by 69% after stimulation with ADP. In addition, aggregation induced by collagen, protease-activating receptor-4 (PAR-4) peptide, and phorbol myristate 13-acetate was reduced by 34%, 45%, and 55%, respectively (Figure 2A and 2B). Cross-activation experiments in which SR-BIϩ/ϩ platelets were resuspended in SR-BIϪ/Ϫ plasma showed that the aggregation response of these platelets after stimulation by the PAR-4 peptide was reduced compared with SR-BIϩ/ϩ platelets in autologous plasma ( Figure 2C ). Thus, SR-BIϩ/ϩ platelets in SR-BIϪ/Ϫ plasma seemed to rapidly acquire features of SR-BIϪ/Ϫ platelets. Because plasma HDL-cholesterol levels were increased in SR-BIϪ/Ϫ mice and HDL has been described to inhibit platelet aggregation, 4,5 the observed inhibition of aggregation of SR-BIϪ/Ϫ platelets in autologous plasma, as well as SR-BIϩ/ϩ platelets in SR-BIϪ/Ϫ plasma, could well have been caused by the increased plasma HDL level. However, similar results of a reduced aggregation response were found with plasma-free washed platelet suspensions stimulated with ADP or phorbol myristate 13-acetate (supplemental Figure I ). In addition, incubation of SR-BIϪ/Ϫ platelets in SR-BIϩ/ϩ plasma did not improve the aggregation response compared with SR-BIϪ/Ϫ platelets in SR-BIϪ/Ϫ plasma ( Figure 2C ). These findings suggest that the absence of SR-BI on platelets is responsible for the reduced platelet aggregation of SR-BIϪ/Ϫ platelets. However, because cholesterol trafficking between cells and plasma (lipoproteins) is accelerated when SR-BI is expressed, 30 differences in platelet aggregation might also be explained by differences in cholesterol efflux and thus differences in cholesterol content.
The aggregation response of SR-BIϩ/Ϫ platelets was not different from the aggregation response of SR-BIϩ/ϩ platelets (data not shown).
Increased Susceptibility to FeCl 3 -Induced Thrombosis in Mice Lacking SR-BI
Platelets play a crucial role in atherothrombosis. We used the FeCl 3 acute injury model, in which platelet-rich thrombi are formed that are morphologically similar to those found in humans, 31 to investigate the importance of SR-BI in the formation of a pathological, occlusive thrombus in vivo. In this model, acute arterial injury was induced in the left carotid artery by application of 40% FeCl 3 to the adventitial surface of the artery. Thrombus formation was A, PRP was isolated from SR-BIϩ/ϩ (black lines) and SR-BIϪ/Ϫ (gray lines) mice, platelet count was adjusted with platelet-poor plasma (PPP) to 2ϫ10 11 platelets/L, and platelets were stimulated with 25 mol/L ADP, 5 g/mL collagen, 1 mmol/L PAR-4 peptide, or 0.5 g/mL phorbol myristate 13-acetate (PMA). Optical aggregation was measured at 37°C and at a stirring speed of 1000 rpm. Results shown are the mean of 3 independent traces. B, Maximal aggregation at 750 seconds after stimulation of SR-BIϩ/ϩ (white bars) or SR-BIϪ/Ϫ (black bars) PRP with ADP, collagen, PAR-4 peptide, or PMA. Shown are meansϮSD, nϭ3, *PϽ0.05, **PϽ0.01, ***PϽ0.001. C, SR-BIϩ/ϩ or SR-BIϪ/Ϫ platelets were incubated in either SR-BIϩ/ϩ or SR-BIϪ/Ϫ plasma, platelet count was adjusted with PPP to 2ϫ10 11 platelets/L, and platelet aggregation was induced by 1 mmol/L PAR-4 peptide. Results shown are the mean of 3 independent traces. assessed by determining the time to occlusion (TTO) of the artery, which was measured by monitoring the carotid blood flow using an ultrasonic Doppler flow probe. SR-BIϩ/ϩ mice developed total arterial occlusion after 24Ϯ2 minutes ( Figure 3 ). Interestingly, the TTO in SR-BIϪ/Ϫ mice was reduced by 1.8-fold to only 13Ϯ1 minutes (PϽ0.001), indicating that in the absence of SR-BI, mice are more susceptible to thrombosis. In SR-BIϩ/Ϫ mice, arterial occlusion was reached after 18Ϯ1 minutes, which was faster than the TTO observed in SR-BIϩ/ϩ mice (Pϭ0.011) but significantly slower than the TTO in SR-BIϪ/Ϫ mice (Pϭ0.015).
The capacity of the endothelium to generate prostacyclin, a potent platelet inhibitor and vasodilator, might affect thrombosis susceptibility and was measured as the metabolite 2,3-dinor 6-keto prostaglandin F 1␣ in urine. No significant difference was observed between the urinary 2,3-dinor 6-keto prostaglandin F 1␣ levels of SR-BIϩ/ϩ and SR-BIϪ/Ϫ mice (0.5Ϯ0.1 ng/mg creatinine versus 0.8Ϯ0.2 ng/mg creatinine, respectively; Pϭ0.245), indicating a similar platelet inhibition and vasodilation and no additional effect on susceptibility to thrombosis.
SR-BI-Deficient Platelets Circulate in an Activated State
Interestingly, the enhanced thrombosis susceptibility developed despite the lower ex vivo platelet aggregation response observed in SR-BIϪ/Ϫ mice. To determine whether the responsiveness of platelets was altered because of the absence of SR-BI, thereby increasing the susceptibility to thrombosis, we studied the activation state of circulating platelets. On platelet activation, integrin ␣ IIb ␤ 3 changes its conformation to a high-affinity state in which it is able to bind its ligands. In addition, activated platelets express P-selectin on their surface after fusion of the granular membranes of ␣-granules with the plasma membrane. Hence, the presence of both active integrin ␣ IIb ␤ 3 and surface-expressed P-selectin was determined as a measure of platelet activation. Interestingly, we measured 3.2-fold more integrin ␣ IIb ␤ 3 in the active high-affinity conformation (relative to the amount of integrin ␣ IIb ␤ 3 protein) on platelets from SR-BIϪ/Ϫ mice (0.36Ϯ0.04 for SR-BIϪ/Ϫ platelets versus 0.11Ϯ0.04 for SR-BIϩ/ϩ platelets; PϽ0.001; Figure 4A ) and 4-fold more than on the SR-BIϩ/Ϫ platelets (0.09Ϯ0.04; PϽ0.001). Correspondingly, platelets from SR-BIϪ/Ϫ mice in their basal activation state expressed 1.4-fold more P-selectin (39.0Ϯ5.8% for SR-BIϪ/Ϫ platelets versus 27.5Ϯ3.0% for SR-BIϩ/ϩ platelets; Pϭ0.02, or versus 30.8Ϯ2.8% for SR-BIϩ/Ϫ platelets; Pϭ0.05, Figure 4B ). On activation, platelets synthesize thromboxane A 2 (TxA 2 ) through the cyclooxygenase-1 pathway. 32, 33 TxA 2 is a vasoconstrictor and platelet-aggregating agent, which on release into the circulation will bind its platelet thromboxane prostanoid ␣/␤ receptor to initiate reinforcing activation pathways. The intake of aspirin, an inhibitor of TxA 2 synthesis, aids in the prevention of arterial thrombosis, 34 which implicates TxA 2 as an important factor in cardiovascular disease. The presence of the TxA 2 metabolite 2,3-dinor TxB 2 in urine of mice is thus also a marker for platelet activation. A tendency, although not a significant one, toward increased levels of 2,3-dinor TxB 2 in the urine of SR-BIϪ/Ϫ mice was observed (17.0Ϯ3.6 ng/mg creatinine for SR-BIϪ/Ϫ mice versus 10.8Ϯ2.5 ng/mg creatinine for SR-BIϩ/ϩ mice, Figure 4C ). Together, these findings indicate that platelets from SR-BIϪ/Ϫ mice circulated in a more activated state in vivo compared with wild-type or SR-BIϩ/Ϫ platelets.
To investigate the functional consequences of the activated state of circulating platelets from SR-BIϪ/Ϫ mice, platelets were allowed to adhere to and spread on immobilized fibrinogen under static conditions for 60 minutes. After 30 minutes, the first SR-BIϩ/ϩ platelets showed signs of spreading. In contrast, the first platelets from SR-BIϪ/Ϫ mice had already started to spread after 15 minutes, and this number increased in time ( Figure 4D ). Thus, platelets from SR-BIϪ/Ϫ mice spread more easily on immobilized fibrinogen than SR-BIϩ/ϩ platelets, which may explain the observed increased susceptibility to FeCl 3 -induced thrombosis.
To investigate whether the increased basal activity of platelets from SR-BIϪ/Ϫ mice was due to the increased UC:TC ratio in SR-BIϪ/Ϫ plasma, the amount of integrin ␣ IIb ␤ 3 in the active high-affinity conformation was measured after incubation of SR-BIϩ/ϩ platelets in SR-BIϪ/Ϫ plasma, and vice versa. We observed a trend toward expression of more active integrin ␣ IIb ␤ 3 on SR-BIϩ/ϩ platelets in SR-BIϪ/Ϫ plasma compared with SR-BIϩ/ϩ platelets in SR-BIϩ/ϩ plasma, whereas expression of active integrin ␣ IIb ␤ 3 on platelets from SR-BIϪ/Ϫ mice in SR-BIϩ/ϩ plasma was significantly reduced compared with SR-BIϪ/Ϫ platelets in autologous plasma ( Figure 4E ). These findings suggest that the UC:TC ratio plays a role in platelet responsiveness of SR-BIϪ/Ϫ platelets. The cross-activation experiment did not show a complete reversal of the integrin activity, which may indicate that incubation of SR-BIϩ/ϩ platelets in SR-BIϪ/Ϫ plasma, and vice versa, for 90 minutes is not sufficient to completely reverse integrin activity. In SR-BIϩ/ϩ and SR-BIϪ/Ϫ mice, the left carotid artery was dissected and exposed to a small strip of filter paper saturated with 40% FeCl 3 for 3 minutes to initiate the development of a stable completely occlusive thrombus. For analysis of thrombus formation, the carotid blood flow was monitored continuously using an ultrasonic laser Doppler flow probe to measure the time between the FeCl 3 application and zero blood flow velocity (TTO). Results are expressed as meansϮSD for groups of 7 mice. *PϽ0.05, ***PϽ0.001.
A High-Fat/High-Cholesterol Diet Enhances the Effects of SR-BI Deficiency on Platelet Responsiveness
Challenging SR-BIϩ/ϩ and SR-BIϪ/Ϫ mice with a high-fat/ high-cholesterol Western-type diet, containing 15% (w/w) cacao butter and 0.25% (w/w) cholesterol, induced a dramatic further increase of the unesterified cholesterol (2.8-fold) and total cholesterol (6.4-fold) levels in the circulation of SR-BIϪ/Ϫ mice (supplemental Table I ), resulting in a further 2.3-fold increase of the UC:TC ratio compared with SR-BIϩ/ϩ mice (PϽ0.001). The Western-type diet challenge did not change the platelet count of SR-BIϩ/ϩ mice (chow versus Western-type diet: 921Ϯ147ϫ10 9 platelets/L versus 965Ϯ280ϫ10 9 platelets/L; Pϭ0.75) but further decreased the platelet count of SR-BIϪ/Ϫ mice (415Ϯ97ϫ10 9 platelets/L versus 319Ϯ83ϫ10 9 platelets/L; Pϭ0.047; Figure 5A ). Similarly, the size of platelets from SR-BIϪ/Ϫ mice increased further (from 7.3Ϯ0.4 to 8.1Ϯ0.5 fL; PϽ0.001), whereas no effect was observed regarding the size of SR-BIϩ/ϩ platelets (6.0Ϯ0.2 fL on both chow and Western-type diet; Figure 5B ). The urinary levels of 2,3-dinor TxB 2 of SR-BIϪ/Ϫ mice were increased 1.7-fold from 28.8Ϯ4.4 ng/mg creatinine for SR-BIϩ/ϩ mice to 49.8.0Ϯ1.4 ng/mg creatinine for SR-BIϪ/Ϫ mice (Pϭ0.012; Figure 5C ), indicating that platelets from SR-BIϪ/Ϫ mice in a high-cholesterol environment were even more active in vivo. As a result, diet-induced hypercholesterolemia in SR-BIϪ/Ϫ mice also further decreased the ex vivo platelet aggregation response (Figures 2A  and 5D ). Together, these findings indicate that Western-type diet-induced hypercholesterolemia in SR-BIϪ/Ϫ mice further enhanced the platelet characteristics that were observed while the mice were fed a regular chow diet.
Platelet-Specific Deletion of SR-BI by Bone Marrow Transplantation Does Not Affect Platelet Responsiveness
Transplantation of bone marrow offers a unique opportunity to specifically replace genes in cells from hematopoietic origin, including platelets, without affecting plasma cholesterol levels. 35 Therefore, to assess the influence of the UC:TC ratio in plasma on platelet function, bone marrow from either SR-BIϩ/ϩ or SR-BIϪ/Ϫ mice was transplanted into SR-BIϩ/ϩ mice. Successful reconstitution of recipients with hematopoietic donor cells was established by polymerase chain reaction-assisted amplification. Genomic DNA isolated from the recipient mice, transplanted with bone marrow from SR-BIϪ/Ϫ mice, contained a prominent band indicative of the disrupted allele, whereas only a small band was visible representing the SR-BIϩ/ϩ allele (supplemental Figure II) . The control transplanted mice only displayed the SR-BIϩ/ϩ band, indicating that the bone marrow transfer was successful. Selective disruption of SR-BI in bone marrow-derived cells by transplantation of SR-BIϪ/Ϫ bone marrow into SR-BIϩ/ϩ mice did not alter the plasma UC:TC ratio compared with control transplanted SR-BIϩ/ϩ mice (supplemental Table II ). Moreover, platelet count, size, unesterified cholesterol content determined after Filipin III staining, PAR-4 peptide-induced platelet aggregation, and basal activation state were also not affected ( Figure 6 ). Together, these findings indicate that changes in plasma cholesterol levels induced by the absence of SR-BI appear to be responsible for the observed changes in responsiveness of platelets of SR-BIϪ/Ϫ mice.
Discussion
SR-BI has a distinctive role in HDL metabolism and reverse cholesterol transport in vivo. 11,14 -16,20 Targeted disruption of SR-BI in mice causes hypercholesterolemia, mainly because of abnormally large HDL particles containing high levels of both unesterified and esterified cholesterol, resulting in an unusually high UC:TC ratio (supplemental Table I ). 15, 21 The high UC:TC ratio observed in SR-BI-deficient mice was associated with macrothrombocytopenia, which confirms recent findings 28 showing a 62% reduction in the blood platelet count and a 1.3-fold increase in size when comparing platelets from SR-BIϪ/Ϫ mice with those from SR-BIϩ/ϩ or SR-BIϩ/Ϫ mice. The observed macrothrombocytopenia was due to high platelet clearance rates, an increased intracellular cholesterol content, and abnormal platelet morphologies. The latter included an increase in size and the presence of multilamellar structures, probably for accommodation of excess unesterified cholesterol. Reciprocal infusion of biotinylated platelets from SR-BIϩ/ϩ or SR-BIϪ/Ϫ donor mice into SR-BIϩ/ϩ or SR-BIϪ/Ϫ recipient mice, or vice versa, resulted in intracellular unesterified cholesterol levels in the infused platelets that were virtually identical to those of resident platelets. 28 Accumulation of unesterified cholesterol in the SR-BIϪ/Ϫ platelets is thus most likely the result of nonspecific lipid exchange from the abnormally unesterified cholesterol-rich HDL particles that accumulate in SR-BIϪ/Ϫ mice and not a direct effect of the absence of SR-BI on the platelets. In addition to these reported effects on platelet morphology, the current study shows the effects of SR-BI deficiency in mice on platelet physiology. Application of FeCl 3 to the adventitial surface of the carotid artery causes endothelial denudation, resulting in the formation of occluding platelet-rich thrombi 36 that are very similar to those found in humans. 31 Immediately after injury, resting platelets will adhere to exposed subendothelium and become activated by strong agonists present at the site of injury, including collagen and thrombin. In the FeCl 3 acute injury model, the measured TTO in SR-BIϪ/Ϫ mice was reduced compared with the SR-BIϩ/ϩ mice, indicating that platelets from SR-BIϪ/Ϫ mice are more susceptible to forming occluding thrombi. The increased susceptibility may be explained by the fact that in the absence of SR-BI, platelets circulate in an activated state, as observed by the increase in surface-expressed P-selectin (supplemental Figure III) , the high level of TxB 2 metabolites in the urine, and the increased expression of active integrin ␣ IIb ␤ 3 , which are all markers for platelet activation. Integrin ␣ IIb ␤ 3 is a prominent platelet integrin, which on activation is capable of binding several adhesive proteins, including fibrinogen, to support platelet aggregation. It is also involved in the formation of a network of signaling and structural proteins that strongly interacts with the actin cytoskeleton. This network of proteins is located in cholesterol-rich domains, where they are suggested to be important in the platelet response to stimuli and in stabilizing platelet aggregates. 37 Interestingly, cholesterol depletion affects, for example, platelet aggregation. 38 Furthermore, platelet adhesion to fibrinogen is dependent on the presence of intact integrin ␣ IIb ␤ 3 -containing cholesterol-rich domains at the tips of filopodia, 39 indicating that the function of integrin ␣ IIb ␤ 3 is dependent on the integrity of the cholesterol-rich domains. Hence, an increase in the free cholesterol content of platelets from SR-BI-deficient mice may have an enhancing effect on platelet function because of an increase in cholesterol-rich domains and therefore the activity and functioning of integrin ␣ IIb ␤ 3 . Indeed, in the absence of SR-BI, platelets showed an increased adherence to immobilized fibrinogen ex vivo. Fibrinogen binding is known to depend on prior activation of integrin ␣ IIb ␤ 3 , but surface-coated fibrinogen also binds to the closed conformation present on resting platelets. 40 Thus, in addition to binding of immobilized fibrinogen to integrin ␣ IIb ␤ 3 in the closed conformation, adhesion to and spreading on immobilized fibrinogen by platelets from SR-BIϪ/Ϫ mice might well be facilitated by the increased number of integrin ␣ IIb ␤ 3 molecules in the high-affinity ligand-binding conformation.
We also observed a reduction of the TTO in SR-BIϩ/Ϫ mice in the FeCl 3 acute injury model compared with the SR-BIϩ/ϩ mice, but TTO was significantly longer than that of SR-BIϪ/Ϫ mice. Surprisingly, SR-BIϩ/Ϫ mice showed no signs of abnormal platelet characteristics, and prostacyclin generation was similar in SR-BIϩ/ϩ and SR-BIϪ/Ϫ mice and therefore probably also in SR-BIϩ/Ϫ mice, indicating similar platelet inhibition and vasodilation. FeCl 3 -induced acute arterial injury is based on the generation of reactive oxygen species that cause endothelial denudation. 36 In addition to being a key regulator of HDL metabolism, SR-BI is also involved in maintaining endothelial integrity after injury. This process is dependent on signaling via Src kinases, phosphatidylinositol 3-kinase, and p42/44 mitogen-activated protein kinase, leading to the activation of Rac GTP hydrolase and subsequent rearrangement of the actin cytoskeleton, finally resulting in endothelial repair. Maintenance of endothelial integrity is impaired in SR-BIϪ/Ϫ mice 41 and may also be affected in SR-BIϩ/Ϫ mice, resulting in faster platelet adhesion than in control SR-BIϩ/ϩ mice. Consequently, the quick formation of occlusive thrombi observed in SR-BIϪ/Ϫ mice may thus be the direct result of the combination of enhanced platelet responsiveness and impaired ability to maintain endothelial integrity.
Imachi et al reported reduced levels of SR-BI on platelets from atherosclerotic disease patients that were inversely correlated with the intracellular cholesterol content of platelets and their ability to aggregate. 27 Moreover, platelets of hypercholesterolemic patients are hyperreactive and show hyperaggregability both in vivo and in vitro because of an increased cholesterol content, 42, 43 whereas cholesterol depletion by cyclodextrin impedes platelet activation. 44 Surprisingly, the aggregation response of platelets from SR-BIϪ/Ϫ mice was inhibited after stimulation by different agonists, despite their increased cholesterol content and the increased thrombosis susceptibility. This discrepancy may be explained by the highly activated state of the murine platelets in the circulation. On activation, platelets form and release TxA 2 and secrete active granule contents, including ADP, to initiate the activation of reinforcing activation pathways to aid in the induction of stable platelet activation. 45, 46 The magnitude and rate of platelet granule secretion and TxA 2 generation is related to the potency of the stimulus: strong agonists such as thrombin and collagen appear to release nearly all granules, Figure 6 . Effects of platelet-specific SR-BI deficiency on platelet count, platelet size, cholesterol content, and platelet reactivity in normolipidemic conditions of SR-BIϩ/ϩ mice. Platelet count (A) and mean platelet volume (B) in whole blood from chimeric SR-BIϩ/ϩ mice with SR-BIϩ/ϩ or SR-BIϪ/Ϫ bone marrow (BM), adhesion to and spreading of platelets to immobilized fibrinogen (C), the activity of integrin ␣ IIb ␤ 3 relative to total integrin ␣ IIb ␤ 3 protein on circulating platelets in whole blood (D), and aggregation of washed platelet suspensions in response to PAR-4 peptide (E and F) were measured as described in the legends to Figures 1, 4 , and 2, respectively. Results are expressed as meansϮSD, nϭ3 to 5.
whereas the degree of secretion will be less when platelets are stimulated by ADP. 47 Prolonged exposure of platelets to TxA 2 or ADP desensitizes the general platelet response because of desensitization of both the thromboxane prostanoid ␣/␤ receptor for TxA 2 and the P2Y receptors for ADP. 48 Hence, because of the activated state of platelets from SR-BIϪ/Ϫ mice in vivo, these platelets may have been subject to prolonged exposure to both ADP and TxA 2 , which may have resulted in desensitization of the receptors for TxA 2 and ADP that are essential for positive feedback mechanisms to enhance the platelet response. As a result, ex vivo aggregation of platelets from SR-BIϪ/Ϫ mice may be reduced in response to agonist stimulation compared with SR-BIϩ/ϩ platelets, which responded normally. This is strengthened by the observation that SR-BIϩ/ϩ platelets, after a prolonged incubation in SR-BIϪ/Ϫ plasma, also showed an impaired platelet response. However, this is subject to further investigation, also because differences in cholesterol efflux and therefore differences in intracellular cholesterol content due to the absence or presence of SR-BI 30 may affect the platelet aggregation response.
When mice were fed a high-fat/high-cholesterol Westerntype diet, the plasma UC:TC ratio was increased further, as was the size of SR-BIϪ/Ϫ platelets, probably because of a further increase of the intracellular cholesterol content. Moreover, under the influence of high cholesterol levels, SR-BIϪ/Ϫ platelets produced more TxA 2 , indicating that platelets were even more active. Praticò et al 32 observed an increase in endogenous TxA 2 biosynthesis in mice deficient for either apolipoprotein E or the low-density lipoprotein receptor and on a Western-type diet, which are murine models for atherosclerosis. The increased TxA 2 generation was the result of increased in vivo platelet activation. Under the influence of diet-induced hypercholesterolemia in SR-BIϪ/Ϫ mice, the aggregation response decreased further compared with platelets on a chow diet, which is in accordance with the higher activation state of SR-BIϪ/Ϫ platelets in a high-cholesterol environment, pointing at the influence of cholesterol on platelet responsiveness. To investigate the specific influence of plasma cholesterol on platelet responsiveness, SR-BI was specifically disrupted in bone marrowderived cells from SR-BIϩ/ϩ mice by a bone marrow transplantation approach, which did not change the UC:TC ratio in plasma compared with control mice. Platelet-specific deletion of SR-BI did not affect platelet count, size, intracellular cholesterol content, or platelet reactivity compared with control mice, indicating that SR-BI modulates platelet function through regulation of plasma cholesterol levels.
The observation that changes in the plasma UC:TC ratio were responsible for the altered responsiveness of platelets of SR-BI-deficient mice may have important pathophysiological consequences for other disease states that are also characterized by elevated plasma levels of unesterified cholesterol, such as familial lecithin:cholesterol acyltransferase (LCAT) deficiency. The absence of LCAT, a plasma enzyme that esterifies free cholesterol present in circulating plasma lipoproteins, is associated with elevated levels of unesterified cholesterol and a decreased level of esterified cholesterol, fasting hypertriglyceridemia, and multiple blood cell anom-alies. 49 Only a few studies have described the effects of familial LCAT deficiency on platelet responsiveness. These studies demonstrated that platelets from patients with familial LCAT deficiency display decreased platelet adhesiveness in the glass bead filter method of Hellem 50 and a reduced sensitivity to low concentrations of thrombin. 51 Clearly, further research is required to conclusively establish the importance of the elevated unesterified cholesterol levels in familial LCAT deficiency on platelet function.
In conclusion, disruption of SR-BI induces a rise in the plasma UC:TC ratio, leading to an increased activation status of circulating platelets and enhanced arterial thrombosis (supplemental Figure III) , which may contribute to the enhanced atherosclerotic lesion development in SR-BIdeficient mice. 21, 22 Hence, the function of SR-BI in maintaining normal cholesterol homeostasis and a low atherosclerosis susceptibility is indirectly also essential for maintaining normal platelet function and prevention of thrombosis.
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